G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 

Podcast

Hear 
G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences.
Hear the podcast 

Burrill Conferences

Sponsors

Presented withPlatinumGoldSilverBronzeEvent Partners

Life Sciences Conferences

The Burrill India Life Sciences Meeting

Agenda

Preliminary Agenda

June 16, 2008

7:30 a.m. – 8:00 a.m.  

Breakfast & Registration

                                                           

8:00 a.m. – 8:45 a.m.  

Keynote Presentation: 

Biotech State of the Industry – A Global Look

G. Steven Burrill, CEO, Burrill & Company

 

8:45 a.m. – 9:00 a.m.  

China / San Diego / California - Global Biotech Cluster 

Joe Panetta, President & CEO, BIOCOM

  

9:00 a.m. -9:15 a.m 

Break

           

9:15 a.m. – 10:30 a.m.

The Life Science Revolution in India

      Areas of Innovation that India is Globally Competitive in Today

       - Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics

       - Ajit Singh, PhD, CEO, Siemens Healthcare, Image & Knowledge 

         Management Group

   •   Reaching Beyond: From Domestic to International Markets

       - Arun Chandavarkar, PhD, COO, Biocon

       - Greg Wiederrecht, PhD, VP External Scientific Affairs, Merck

   •   Creating Value in a Global Marketplace

       - Sreeni Devidas, PhD VP, Business Development, GVK BioSciences

       - Dr. Swati Piramal, Director, Strategic Alliances & Communications, Nicholas  

         Piramal India Ltd

  

Moderated by: Tania Fernandez, PhD, Director India, Burrill & Comapny


10:30 a.m – 11:45 a.m.          

Models of Global Growth by Leading Indian Companies

   •   Expansion into US Specialty Therapeutics

       - Jeffrey Wasserstein, EVP, North America Specialty, Dr. Reddy’s  

         Laboratories

   •   Leadership in Global Generics through Regional Expansion

        - Shyam Bishen, PhD, VP, Corporate Development, Ranbaxy Pharmaceuticals

   •   Transitioning from Services to Proprietary Drug Development

        - Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences

   •   Vertical Integration Via M&A

        - Sridhar Mosur, President & CEO, Jubilant Discovery Services &

          Jubilant Biosys   

   •   Growth Through Strategic Partnerships

       - Andres Liivak, Partner, Reed Smith

  

Moderated by: Mohan Iyer, Managing Director, Merchant Banking Group, Burrill

                        & Company   

             

11:45 a.m. – 12:45 p.m.

Networking Lunch

 

12:45 p.m. – 2:00 p.m.           

Capital Markets in India

   •   Where is the Capital Coming From?

        -  Anna Lavelle, PhD, CEO & Executive Director, AusBiotech 

        - Robert Power, VP, Investment Banking, NYSE  Euronext 

        - Villoo Morawalla Pate, PhD, Founder and Managing Director of Avestha

         Gengraine Technologies

   •   How Can You Build Value in Indian Life Science Companies?

 - Dr. Anula Jayasuriya, PhD, Managing Director, Evolvence India Life Science

  Fund   

        -Yatin Mundkur, Partner, Artiman Ventures  

Moderated by: Roger Wyse, PhD, Managing Director, Burrill & Company


2:00 p.m. – 2:45 p.m.      

Shining examples of Indian life science companies on the horizon

  • Advinus (Pharma): Kasim Mookhtiar, PhD, CSO & SVP
  • Chembiotek- A TCG Lifesciences Co. (Discovery Services): Ashis Saha, PhD, VP, Discovery
  • MetaHelix Life Sciences (Agbio): Dr. Vasudera Rao, President, Agriculture Technologies          
  • Ocimum Biosolutions (Services): Anuradha Acharya, CEO

Moderated by: Ganesh Kishore, PhD, Managing Director, Burrill & Company  

                              

2:45 p.m. – 3:00 p.m.             

Break

 

3:00 p.m. – 3:45 p.m. 

Year 2020 – China/India: A Comparison      

   •   Futurist who can find what India will look like in 2020:

        Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics

   •   Futurist who can find what China will look like in 2020:

       Hongguang Wang,PhD, Director General, China National Center for       

       Biotechnology

Moderated by: G. Steven Burrill, CEO, Burrill & Company

           

3:45 p.m. – 4:00 p.m. 

Closing Remarks

G. Steven Burrill, CEO, Burrill & Company

 

4:00 p.m. – 5:30 p.m. 

Networking Reception

Sponsored by:  Wilson Sonsini Goodrich & Rosati